CM
Caption Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-57,000
| Closed | -$45K | – | 693 |
|
|
2025
Q1 | $45K | Buy |
+57,000
| New | +$45K | ﹤0.01% | 476 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 560 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 584 |
|
|
2021
Q4 | – | Sell |
-24,000
| Closed | -$1.42M | – | 699 |
|
|
2021
Q3 | $1.42M | Buy |
24,000
+17,000
| +243% | +$1.01M | 0.02% | 216 |
|
|
2021
Q2 | $609K | Buy |
+7,000
| New | +$609K | 0.01% | 237 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 514 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 442 |
|
|
2020
Q3 | – | Sell |
-15,300
| Closed | -$524K | – | 446 |
|
|
2020
Q2 | $524K | Sell |
15,300
-31,400
| -67% | -$1.08M | 0.02% | 157 |
|
|
2020
Q1 | $1.04M | Buy |
46,700
+6,700
| +17% | +$149K | 0.06% | 90 |
|
|
2019
Q4 | $783K | Buy |
+40,000
| New | +$783K | 0.03% | 131 |
|